Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in HeLa cells

Molecular Biology Reports

Volumn 40, Issue 12, 2013, Pages 6757-6764

  Cocco, Emiliano ^a,b   Porrini, Vanessa ^a   Derosas, Manuela ^a,c   Nardi, Veronica ^a   Biasiotto, Giorgio ^a   Maccarinelli, Federica ^a   Zanella, Isabella ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cardiotoxicity; Doxorubicin; Hepcidin; Iron; Mitochondrial ferritin

Indexed keywords

ACONITATE HYDRATASE; DOXORUBICIN; FERRITIN; FRATAXIN; MANGANESE SUPEROXIDE DISMUTASE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IRON HOMEOSTASIS; IRON METABOLISM; IRON TRANSPORT; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CYTOSOL; DOXORUBICIN; HELA CELLS; HOMEOSTASIS; HUMANS; IRON; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MYOCARDIUM; PROTECTIVE AGENTS;

EID: 84890376183     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2792-z     Document Type: Article

References (25)

1. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185-229
2. Simůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61:154-171
3. Hershko C, Link G, Tzahor M, Kaltwasser JP, Athias P, Grynberg A, Pinson A (1993) Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture. J Lab Clin Med 122:245-251
4. Panjrath GS, Patel V, Valdiviezo CI, Narula N, Narula J, Jain D (2007) Potentiation of doxorubicin cardiotoxicity by iron loading in a rodent model. J Am Coll Cardiol 49:2457-2464
5. Miranda CJ, Makui H, Soares RJ, Bilodeau M, Mui J, Vali H, Bertrand R, Andrews NC, Santos MM (2003) Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 102:2574-2580
6. Cascales A, Sánchez-Vega B, Navarro N, Pastor-Quirante F, Corral J, Vicente V, de la Peña FA (2012) Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation. Int J Cardiol 154:282-286
7. Kang YJ, Chen Y, Epstein PN (1996) Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271:12610-12616
8. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK (1996) The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 98:1253-1260
9. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Rahmanto YS, Sheftel AD, Ponka P (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci USA 107:10775-10782
10. Goormaghtigh E, Huart P, Praet M, Brasseur R, Ruysschaert JM (1990) Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys Chem 35:247-257
11. Corsi B, Cozzi A, Arosio P, Drysdale J, Santambrogio P, Campanella A, Biasiotto G, Albertini A, Levi S (2002) Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277:22430-22437
12. Santambrogio P, Biasiotto G, Sancito F, Olivieri S, Arosio P, Levi S (2007) Mitochondrial ferritin expression in adult mouse tissues. J Histochem Cytochem 55:1129-1137
13. Zanella I, Derosas M, Corrado M, Cocco E, Cavadini P, Biasiotto G, Poli M, Verardi R, Arosio P (2008) The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Biochim Biophys Acta 1782:90-98
14. Cavadini P, Biasiotto G, Poli M, Levi S, Verardi R, Zanella I, Derosas M, Ingrassia R, Corrado M, Arosio P (2007) RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 109:3552-3559
15. Shi ZH, Nie G, Duan XL, Rouault T, Wu WS, Ning B, Zhang N, Chang YZ, Zhao BL (2010) Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease. Antioxid Redox Signal 13:783-796
16. Campanella A, Rovelli E, Santambrogio P, Cozzi A, Taroni F, Levi S (2009) Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet 18:1-11
17. Corna G, Galy B, Hentze MW, Cairo G (2006) IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice. J Mol Med 84:551-560
18. Corna G, Santambrogio P, Minotti G, Cairo G (2004) Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin. J Biol Chem 279:13738-13745
19. Xu X, Persson HL, Richardson DR (2005) Molecular pharmacology of the interaction of anthracyclines with iron. Mol Pharmacol 68:261-271
20. Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117:4425-4433
21. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H (2007) The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 148:2663-2668
22. Li K, Besse EK, Ha D, Kovtunovych G, Rouault TA (2008) Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum Mol Genet 17:2265-2273
23. Torti FM, Torti SV (2002) Regulation of ferritin genes and protein. Blood 99:3505-3516
24. Anderson CP, Shen M, Eisenstein RS, Leibold EA (2012) Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta 1823:1468-1483
25. Wang J, Fillebeen C, Chen G, Biederbick A, Lill R, Pantopoulos K (2007) Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway. Mol Cell Biol 27:2423-2430